CDC: Children Getting Ill From Ingesting Gel Hand Sanitizer

Share this content:
CDC: Children Getting Ill From Ingesting Gel Hand Sanitizer
CDC: Children Getting Ill From Ingesting Gel Hand Sanitizer

FRIDAY, March 3, 2017 (HealthDay News) -- A rising number of children are becoming ill from ingesting gel hand sanitizer, according to research published in the March 3 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

The CDC researchers tracked illnesses from 2011 to 2014 for children aged 12 and under. The investigators believe some children in the higher age range may be drinking sanitizer because of the product's high alcohol content.

"Older children (aged 6 to 12 years) were more likely to report intentional ingestion and to have adverse health effects and worse outcomes than were younger children, suggesting that older children might be deliberately misusing or abusing alcohol hand sanitizers," the authors write. "During 2011 to 2014, a total of 70,669 hand sanitizer exposures in children at or below 12 years of age were reported, including 65,293 alcohol exposures (92 percent)." Most of these exposures may have been accidental, with 91 percent occurring in children aged 5 and under. But about 6,181 incidents affected children aged 6 to 12, and these had much higher odds of being intentional ingestions.

Compared to nonalcohol-based hand sanitizers, ingestion of alcohol sanitizers was associated with worse symptoms in children, according to the report. While vomiting and eye irritation were the most common symptoms, much more serious events were also recorded, including five cases of coma and three cases involving seizures.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »